The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmurfit Kappa Regulatory News (SKG)

Share Price Information for Smurfit Kappa (SKG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,418.00
Bid: 3,588.00
Ask: 3,060.00
Change: -22.00 (-0.64%)
Spread: -528.00 (-14.716%)
Open: 3,422.00
High: 3,448.00
Low: 3,382.00
Prev. Close: 3,440.00
SKG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.1 - Citibank NA London - Amendment

4 Jun 2018 16:15

RNS Number : 2440Q
Citibank NA
04 June 2018
 

Ap9

 

 

APPENDIX 3 DISCLOSURE FORMS

 

 

Amendment to 2 (a) & 3

 

 

 

FORM 8.1(a)&(b)(i)

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Citibank N.A. London

Company dealt in

Smurfit Kappa Group plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

0.001 Ordinary Shares

Date of dealing

26 March 2018

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

180,282 (0.08%)

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

Ap10

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

Sale

260

34.74

Sale

335

34.60

Sale

43

34.60

Sale

260

34.60

Sale

55

34.60

Sale

206

34.60

Sale

271

34.68

Sale

66

34.68

Sale

139

34.68

Sale

673

34.70

Sale

7

34.48

Sale

677

34.48

Sale

46

34.48

Sale

190

34.52

Sale

479

34.52

Sale

62

34.08

Sale

153

34.08

Sale

80

34.04

Sale

47

34.56

Sale

155

34.56

Sale

89

34.56

Sale

34

34.20

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap11

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  YES/NO

 

Date of disclosure

04 June 2018

Contact name

Connor McLaughlin

Telephone number

02895955328

Name of offeree/offeror with which acting in concert

Smurfit Kappa Group plc

Specify category and nature of acting in concert status

 Financial Advisor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEFKQDDPBKDBAK
Date   Source Headline
23rd Apr 20249:35 amRNSHolding(s) in Company
22nd Apr 20245:23 pmRNSHolding(s) in Company
22nd Apr 20245:18 pmRNSHolding(s) in Company
18th Apr 202410:29 amRNSHolding(s) in Company
17th Apr 20244:10 pmRNSHolding(s) in Company
17th Apr 202410:27 amRNSHolding(s) in Company
16th Apr 20245:22 pmRNSHolding(s) in Company
16th Apr 202412:34 pmRNSHolding(s) in Company
12th Apr 20249:45 amRNSHolding(s) in Company
11th Apr 20243:36 pmRNSHolding(s) in Company
11th Apr 202410:27 amRNSHolding(s) in Company
9th Apr 202410:21 amRNSHolding(s) in Company
8th Apr 202411:29 amRNSHolding(s) in Company
2nd Apr 20245:24 pmRNSHolding(s) in Company
2nd Apr 20245:17 pmRNSHolding(s) in Company
2nd Apr 202410:22 amRNSHolding(s) in Company
28th Mar 20245:08 pmRNSHolding(s) in Company
26th Mar 20245:05 pmRNSDirector/PDMR Shareholding
25th Mar 20242:28 pmRNSHolding(s) in Company
22nd Mar 20244:53 pmRNSHolding(s) in Company
22nd Mar 202410:46 amRNSHolding(s) in Company
21st Mar 20245:16 pmRNSHolding(s) in Company
19th Mar 20243:17 pmRNSHolding(s) in Company
19th Mar 202412:44 pmRNSHolding(s) in Company
19th Mar 202412:28 pmRNSHolding(s) in Company
15th Mar 20244:13 pmRNSDirector/PDMR Shareholding
15th Mar 20243:00 pmRNSPublication of Annual Report and Notice of AGM
15th Mar 20242:43 pmRNSHolding(s) in Company
13th Mar 202410:45 amRNSHolding(s) in Company
6th Mar 202410:34 amRNSHolding(s) in Company
1st Mar 20245:04 pmRNSHolding(s) in Company
29th Feb 20244:42 pmRNSTotal Voting Rights
26th Feb 20249:51 amRNSHolding(s) in Company
21st Feb 20245:16 pmRNSHolding(s) in Company
19th Feb 20249:35 amRNSBlock listing Interim Review
16th Feb 20245:05 pmRNSDirector/PDMR Shareholding
14th Feb 202412:08 pmRNSHolding(s) in Company
14th Feb 202411:08 amRNSHolding(s) in Company
13th Feb 202412:22 pmRNSHolding(s) in Company
6th Feb 20244:14 pmRNSHolding(s) in Company
6th Feb 202412:19 pmRNSHolding(s) in Company
2nd Feb 20245:13 pmRNSHolding(s) in Company
2nd Feb 202412:38 pmRNSHolding(s) in Company
1st Feb 20245:26 pmRNSHolding(s) in Company
30th Jan 20243:44 pmRNSHolding(s) in Company
30th Jan 20243:35 pmRNSHolding(s) in Company
11th Jan 20249:48 amRNSHolding(s) in Company
5th Jan 20244:42 pmRNSHolding(s) in Company
2nd Jan 20242:02 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.